Latus Therapeutics Limited, founded in 2019, is a leading research and experimental development biotech company with a vision to find a cure for cancer. We are specifically looking at the B-cell Lymphomas in order to get a better understanding of the underlying signalling mechanism of the cell and its potential in helping people to combat cancer.
Today, in response to the public health crisis, Latus Therapeutics has refocused its efforts to originate not for profit initiative to find a treatment for the patients tested positive with the COVID-19. At a time when thousands of people around the world are dying every day from the disease and economies are paralysed, this crucial research will utilise existing medicines that have already been shown to prevent the virus from infecting human cells in vitro. More information about the trials can be found on our website. Latus' team is contributing their time for free.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 2 Hinksey Court Church Way, Oxford,ox2 9sx,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.latus-tx.com
- Keywords
- Leiutis Pharmaceuticals LLP.
- HQ
- Oxford
Latus Therapeutics Questions
Latus Therapeutics's website is http://www.latus-tx.com
Latus Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/latus-tx
Latus Therapeutics has
2 employees.
View email and phone details for 2
employees at Latus Therapeutics.
Latus Therapeutics's industry is
Biotechnology Research
Latus Therapeutics's top competitors are
Light Sciences Corporation,
Latus Bio,
Leiutis Pharmaceuticals Llp,
Delphia Therapeutics,
Crs Benelux & France Local Chapter,
Reunion Neuroscience,
Oprl Biosciences Pvt Ltd,
Leiutis Pharmaceuticals Private Limited,
Lattice Therapeutics, Inc,
Latuspet.
Latus Therapeutics's categories are Biotechnology Research
Latus Therapeutics's founding year is 2019
